Cargando…

An Evaluation of Treatment Outcomes in a Cohort of Clients on the DOTS Strategy, 2012–2016

We present, for the first time, an evaluation of treatment outcomes in a cohort at a TB referral centre in the Central Region of Ghana. Of the 213 clients placed on DOTS, 59.2% (126/213) were sputum smear-positive. An overall cure rate of 90.2% (51.6% cured + 37.6% completed) and a death rate of 8.5...

Descripción completa

Detalles Bibliográficos
Autores principales: Tetteh, Ato Kwamena, Agyarko, Edward, Otchere, Joseph, Bimi, Langbong, Ayi, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832068/
https://www.ncbi.nlm.nih.gov/pubmed/29666702
http://dx.doi.org/10.1155/2018/4287842
_version_ 1783303256043159552
author Tetteh, Ato Kwamena
Agyarko, Edward
Otchere, Joseph
Bimi, Langbong
Ayi, Irene
author_facet Tetteh, Ato Kwamena
Agyarko, Edward
Otchere, Joseph
Bimi, Langbong
Ayi, Irene
author_sort Tetteh, Ato Kwamena
collection PubMed
description We present, for the first time, an evaluation of treatment outcomes in a cohort at a TB referral centre in the Central Region of Ghana. Of the 213 clients placed on DOTS, 59.2% (126/213) were sputum smear-positive. An overall cure rate of 90.2% (51.6% cured + 37.6% completed) and a death rate of 8.5% (18/213) were estimated. Of the number of clients who died, 5.7% (12/213) were males (χ (2) = 2.891, p = 0.699; LR = 3.004, p = 0.699). Deaths were only recorded among clients who were > 19 years old (χ (2) = 40.319, p = 0.099; LR = 41.244, p = 0.083). Also, 0.9% (2/213) was lost to follow-up, while 1.4% (3/213) had treatment failure. In total, 13.6% (7.0%, 15/213 males, and 6.6%, 14/213 females) of clients who were placed on DOTS were HIV seropositive. Ages of 40–49 years had the highest number, 13/213 (6.1%), infected with HIV, though the difference among the remaining age groups was not statistically significant (χ (2) = 9.621, p = 0.142). Furthermore, 7.0% (15/213) had TB/HIV coinfection. Out of them, 9 were cured and 5 died at home, while 1 had treatment failure. Tuberculosis/HIV infection prevention advocacy and interventions that address sociodemographic determinants of unfavourable treatment outcomes are urgently required to augment national efforts towards control.
format Online
Article
Text
id pubmed-5832068
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-58320682018-04-17 An Evaluation of Treatment Outcomes in a Cohort of Clients on the DOTS Strategy, 2012–2016 Tetteh, Ato Kwamena Agyarko, Edward Otchere, Joseph Bimi, Langbong Ayi, Irene Tuberc Res Treat Research Article We present, for the first time, an evaluation of treatment outcomes in a cohort at a TB referral centre in the Central Region of Ghana. Of the 213 clients placed on DOTS, 59.2% (126/213) were sputum smear-positive. An overall cure rate of 90.2% (51.6% cured + 37.6% completed) and a death rate of 8.5% (18/213) were estimated. Of the number of clients who died, 5.7% (12/213) were males (χ (2) = 2.891, p = 0.699; LR = 3.004, p = 0.699). Deaths were only recorded among clients who were > 19 years old (χ (2) = 40.319, p = 0.099; LR = 41.244, p = 0.083). Also, 0.9% (2/213) was lost to follow-up, while 1.4% (3/213) had treatment failure. In total, 13.6% (7.0%, 15/213 males, and 6.6%, 14/213 females) of clients who were placed on DOTS were HIV seropositive. Ages of 40–49 years had the highest number, 13/213 (6.1%), infected with HIV, though the difference among the remaining age groups was not statistically significant (χ (2) = 9.621, p = 0.142). Furthermore, 7.0% (15/213) had TB/HIV coinfection. Out of them, 9 were cured and 5 died at home, while 1 had treatment failure. Tuberculosis/HIV infection prevention advocacy and interventions that address sociodemographic determinants of unfavourable treatment outcomes are urgently required to augment national efforts towards control. Hindawi 2018-02-15 /pmc/articles/PMC5832068/ /pubmed/29666702 http://dx.doi.org/10.1155/2018/4287842 Text en Copyright © 2018 Ato Kwamena Tetteh et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Tetteh, Ato Kwamena
Agyarko, Edward
Otchere, Joseph
Bimi, Langbong
Ayi, Irene
An Evaluation of Treatment Outcomes in a Cohort of Clients on the DOTS Strategy, 2012–2016
title An Evaluation of Treatment Outcomes in a Cohort of Clients on the DOTS Strategy, 2012–2016
title_full An Evaluation of Treatment Outcomes in a Cohort of Clients on the DOTS Strategy, 2012–2016
title_fullStr An Evaluation of Treatment Outcomes in a Cohort of Clients on the DOTS Strategy, 2012–2016
title_full_unstemmed An Evaluation of Treatment Outcomes in a Cohort of Clients on the DOTS Strategy, 2012–2016
title_short An Evaluation of Treatment Outcomes in a Cohort of Clients on the DOTS Strategy, 2012–2016
title_sort evaluation of treatment outcomes in a cohort of clients on the dots strategy, 2012–2016
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832068/
https://www.ncbi.nlm.nih.gov/pubmed/29666702
http://dx.doi.org/10.1155/2018/4287842
work_keys_str_mv AT tettehatokwamena anevaluationoftreatmentoutcomesinacohortofclientsonthedotsstrategy20122016
AT agyarkoedward anevaluationoftreatmentoutcomesinacohortofclientsonthedotsstrategy20122016
AT otcherejoseph anevaluationoftreatmentoutcomesinacohortofclientsonthedotsstrategy20122016
AT bimilangbong anevaluationoftreatmentoutcomesinacohortofclientsonthedotsstrategy20122016
AT ayiirene anevaluationoftreatmentoutcomesinacohortofclientsonthedotsstrategy20122016
AT tettehatokwamena evaluationoftreatmentoutcomesinacohortofclientsonthedotsstrategy20122016
AT agyarkoedward evaluationoftreatmentoutcomesinacohortofclientsonthedotsstrategy20122016
AT otcherejoseph evaluationoftreatmentoutcomesinacohortofclientsonthedotsstrategy20122016
AT bimilangbong evaluationoftreatmentoutcomesinacohortofclientsonthedotsstrategy20122016
AT ayiirene evaluationoftreatmentoutcomesinacohortofclientsonthedotsstrategy20122016